share_log
Reuters ·  Mar 20 12:30
Icecure Reports Updated Timeline and Progress With FDA Regarding Marketing Authorization for Prosense® Cryoablation in Early-Stage Breast Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 270

Recommended

Write a comment